Tattoo-associated uveitis

Key Points at a Glance

Key Points at a Glance

• Tattoo-associated uveitis is a rare condition that simultaneously presents with granulomatous inflammation at the tattoo site and uveitis.
• First reported in 1952, the number of cases has been increasing with the popularity of tattoos.
• The etiology is hypothesized to be a delayed-type hypersensitivity reaction to tattoo ink or a limited form of sarcoidosis.
• It typically presents as bilateral anterior uveitis or panuveitis.
• Symptoms usually appear within one year after tattooing²⁾.
• Treatment is based on topical steroid eye drops, and systemic steroids or immunosuppressive therapy may be required in severe cases.
• Exclusion of other diseases such as sarcoidosis is important for diagnosis.

1. What is tattoo-associated uveitis?

Tattoo-associated uveitis is a rare disease in which uveitis and granulomatous inflammation at the tattoo site are simultaneously observed in patients with tattoos. It was first reported by Lubeck and Epstein in 1952. Non-caseating granulomas are found at the tattoo site.

In a 2018 review, Kluger classified this disease into three categories ²⁾.

Category 1

Associated with systemic sarcoidosis: Ocular involvement is seen in 25–80% of sarcoidosis patients.

Develops as a form of sarcoid uveitis.

Category 2

Associated with tattoo granuloma: Granulomatous reaction occurs at the tattoo site, accompanied by uveitis.

May not meet the criteria for sarcoidosis.

Category 3

Uveitis after tattooing: No granuloma at the tattoo site.

Tattooing is considered a trigger, but skin inflammation is absent.

Epidemiology

Reports are few, and the exact prevalence is unknown. From 1952 to 2018, only 39 cases of concurrent granulomatous reaction and uveitis from tattoos have been recorded. However, the number of reports is increasing with the spread of tattoos. In the United States, it is estimated that about 25% of adults aged 18–50 have tattoos.

Patients tend to be younger. Associations with black ink tattoos are reported more often than with color tattoos.

Q How rare is tattoo-associated uveitis?

A

A literature review from 1952 to 2018 reported only 39 cases, making it an extremely rare disease. However, underreporting is possible, and the actual prevalence is estimated to be higher.

2. Main Symptoms and Clinical Findings

Subjective Symptoms

With the onset of uveitis, the following symptoms appear. Onset usually occurs within one year after tattooing ²⁾. Symptoms of uveitis and inflammation at the tattoo site occur simultaneously.

• Eye pain: Pain associated with anterior uveitis.
• Redness: Redness of the conjunctiva or sclera.
• Photophobia: Increased sensitivity to light.
• Floaters: Appear when there is inflammation of the vitreous body.
• Decreased visual acuity: Occurs depending on the severity of inflammation.

The tattoo site may be accompanied by the following skin symptoms:

• Erythema/edema: Redness and swelling at the tattoo site.
• Induration/pain: Palpable hard mass and tenderness.
• Desquamation: Exfoliation of the skin surface.

Clinical Findings (Findings Confirmed by Physician Examination)

Generally presents as bilateral anterior uveitis or panuveitis. Findings vary depending on the type of uveitis.

Anterior segment findings:

• Anterior chamber cells and flare: Inflammatory cells and protein leakage in the anterior chamber.
• Keratic precipitates (KP): Large granulomatous KP may be observed.
• Posterior synechiae: Caused by prolonged inflammation.
• Intraocular pressure fluctuation: Can be either elevated or decreased.

Posterior segment findings:

• Vitreous cells: Inflammatory cells floating in the vitreous.
• Snowballs and snowbank: White clump-like deposits in the inferior vitreous.
• Vasculitis: Inflammatory changes of retinal blood vessels.
• Choroiditis: Can cause granulomatous lesions of the choroid.

3. Causes and Risk Factors

Etiology

The etiology is not fully understood. Two main hypotheses have been proposed.

• Delayed-type hypersensitivity reaction: A theory that a cell-mediated immune response to antigens in tattoo ink triggers uveitis in susceptible individuals. Tattoo inks contain compounds that can be toxic, mutagenic, or carcinogenic ¹⁾.
• Limited sarcoidosis: A theory that chronic mild antigenic stimulation by tattoo ink induces a systemic granulomatous reaction in susceptible individuals.

Tattoo ink is a complex mixture of heavy metals and organic compounds that can affect immune function ¹⁾. The ink is poorly regulated, and its ingredients are not standardized.

Risk Factors

Factor	Description
Presence of tattoo	Most important risk factor
Ink color	Often associated with black ink
Age	More common in young people

Prevention and daily care

• If you experience eye redness or vision loss after tattooing, see an ophthalmologist as soon as possible.
• If swelling or pain occurs in the area of a tattoo, consider consulting an ophthalmologist.
• If diagnosed with tattoo-associated uveitis, it is recommended to avoid additional tattoos due to the risk of inflammation recurrence.

Q Does the risk differ depending on the color of the tattoo ink?

A

Reported cases are often associated with black ink tattoos, but a causal relationship with specific colors has not been established. Tattoo ink ingredients are not standardized, so caution is needed regardless of color.

4. Diagnosis and Examination Methods

Clinical Diagnosis

The diagnosis of tattoo-associated uveitis is based on the following two points.

• Presence of a tattoo (especially one with inflammation)
• Presence of uveitis

Exclusion of other potential etiologies, especially sarcoidosis, is essential.

Key points in history taking

For all patients with uveitis, the following should be confirmed.

• Presence and timing of tattoos
• History of inflammation at tattoo sites
• Risk factors for infectious uveitis
• Personal or family history of autoimmune disease

Ophthalmic Examination

A complete ophthalmic examination including dilated fundus examination is necessary. All anterior, intermediate, posterior, and panuveitis should be evaluated. For posterior lesions, macular OCT is useful for detecting and monitoring choroidal granulomas over time.

Exclusion Tests for Sarcoidosis

For patients with tattoo granuloma and uveitis, the following examinations are recommended.

• Imaging tests: Chest X-ray (if abnormal, chest HRCT), electrocardiogram
• Blood tests: CBC (with differential), comprehensive metabolic panel
• Infection screening: Tuberculosis test (e.g., QuantiFERON), syphilis screening
• Sarcoidosis-related: Serum ACE level, lysozyme level

Test item	Purpose
Chest X-ray/HRCT	Evaluation of pulmonary sarcoidosis
ACE/Lysozyme	Auxiliary diagnosis of sarcoidosis
QuantiFERON	Exclusion of tuberculosis

Skin biopsy

Biopsy of an inflamed tattoo site reveals non-caseating granulomas containing tattoo pigment. The presence of tattoo pigment within the granulomas suggests that the pigment may trigger the inflammatory response and lymphocyte activation. However, it is difficult to histologically distinguish foreign body granulomas from sarcoidosis granulomas.

Differential diagnosis

The main diseases to be differentiated are as follows:

Infectious:

• Syphilis
• Tuberculosis
• Toxoplasmosis, toxocariasis
• Bartonellosis, Lyme disease

Non-infectious:

• Sarcoidosis: The most important differential diagnosis.
• Behçet’s disease
• Vogt-Koyanagi-Harada disease (VKH)
• HLA-B27-associated uveitis

Q How to differentiate tattoo-associated uveitis from sarcoidosis?

A

Histologically, it is difficult to completely distinguish the granulomas of the two conditions. Systemic evaluation including chest imaging, serum ACE levels, and lysozyme levels is used to confirm evidence of sarcoidosis. In Kluger’s classification, cases with and without sarcoidosis are categorized separately²⁾.

5. Standard Treatment

Medication Therapy

The basic principle of treatment is suppression of inflammation.

• Topical steroid eye drops: Used as first-line treatment. Betamethasone sodium phosphate (Rinderon®) 0.1% is instilled 4 to 6 times daily depending on the severity of inflammation.
• Mydriatic agents: Tropicamide (Mydrin M®) is used concomitantly to prevent posterior synechiae.
• Systemic steroids: Used when local treatment is insufficient to control inflammation. Options include oral prednisolone or posterior sub-Tenon injection of triamcinolone acetonide.
• Immunosuppressive therapy: In cases where steroids do not provide adequate control, systemic immunosuppressive drugs such as cyclosporine may be necessary. In severe or recurrent cases, lifelong immunosuppressive therapy may be required.

Surgical excision of tattoos

For isolated small tattoos showing inflammation, surgical excision has been reported to improve the condition. Removing the tattoo pigment that causes inflammation may also improve ocular inflammation.

Precautions in treatment

• Laser tattoo removal is not recommended. Laser treatment fragments ink particles, exposing more pigment to the immune system and potentially worsening inflammation¹⁾.
• Additional tattooing should be avoided as it involves new exposure to ink, which may trigger or reactivate ocular inflammation.
• Long-term use of systemic steroids requires attention to side effects such as secondary glaucoma and cataracts.

Management of Complications

Complications associated with uveitis and steroid treatment may include the following:

• Peripheral anterior synechiae and posterior synechiae
• Secondary glaucoma
• Cataracts
• Retinal detachment
• Chorioretinal scar

For elevated intraocular pressure, beta-blockers or carbonic anhydrase inhibitor eye drops are used. Surgery is considered for concurrent cataracts.

6. Pathophysiology and detailed pathogenesis

The pathophysiology of tattoo-associated uveitis is not fully understood, but there are two main hypotheses.

Hypothesis 1: Delayed-type hypersensitivity reaction

Tattoo ink contains compounds that may be toxic, mutagenic, or carcinogenic ¹⁾. In susceptible individuals, a large antigen load in the ink triggers a type IV (delayed-type) hypersensitivity reaction, simultaneously causing granuloma formation at the tattoo site and uveitis.

If tattoo ink directly reaches intraocular structures, it can cause inflammatory reactions, permeability disorders, increased intraocular pressure due to trabecular meshwork damage, and secondary glaucoma ¹⁾.

Hypothesis 2: Limited-type sarcoidosis

This hypothesis proposes that chronic mild antigen stimulation from tattoo ink induces a systemic granulomatous reaction consistent with sarcoidosis in susceptible individuals. In fact, many cases meet the diagnostic criteria for sarcoidosis ²⁾.

Histopathological findings

Biopsy of inflamed tattoo sites reveals the following:

• Non-caseating granuloma: Epithelioid cell granuloma without caseous necrosis.
• Tattoo pigment uptake: Tattoo pigment is present within the granuloma. This finding suggests that the pigment triggers lymphocyte activation and inflammatory response.

Sarcoidosis granulomas and foreign body granulomas are histologically difficult to distinguish, and comprehensive clinical systemic evaluation is required.

In a review by Sullivan et al. (2024), multiple cases of tattoo-associated uveitis have been reported in the context of systemic sarcoidosis or delayed-type hypersensitivity, and it is noted that they can cause vision-threatening complications¹⁾.

---

7. Latest Research and Future Perspectives (Research-stage Reports)

For patients: Please read this

The following content is currently at the research or clinical trial stage and is not standard treatment available at general hospitals. It is reference information for professionals regarding future medical developments.

There are few reported cases of tattoo-related uveitis, and large-scale clinical studies have not yet been conducted. Current knowledge is largely based on case reports and literature reviews.

Future challenges

• Safety regulation of tattoo inks: The ingredients of tattoo inks are not standardized, and regulations are insufficient¹⁾. In Europe, moves to regulate ingredients are seen, such as the publication of an EU report on the safety of tattoo inks.
• Elucidation of the molecular mechanisms of the pathology: If the differences in molecular pathways between delayed-type hypersensitivity reactions and sarcoidosis become clear, it may lead to the identification of therapeutic targets.
• Accumulation of long-term prognosis data: Patients diagnosed with tattoo-associated uveitis are recommended for long-term follow-up even in the absence of sarcoidosis²⁾. Prospective data on long-term prognosis need to be accumulated in the future.

Q Can tattoo-associated uveitis be cured?

A

The prognosis is variable. Many patients improve with topical or systemic steroids, but some require systemic immunosuppressive agents. Severe or recurrent cases may require lifelong treatment. Long-term follow-up is recommended even in cases without sarcoidosis²⁾.

---

8. References

1. Ghalibafan S, Herskowitz WR, Chou BG, Rohowetz LJ, Gutkind NE. Isolated tattoo-associated uveitis without systemic sarcoidosis: a systematic review of case reports. Surv Ophthalmol. 2026;71(2):512-528. doi:10.1016/j.survophthal.2025.09.021. PMID:41043516.
2. Kluger N.. Tattoo-associated uveitis with or without systemic sarcoidosis: a comparative review of the literature. J Eur Acad Dermatol Venereol. 2018;32(11):1852-1861. doi:10.1111/jdv.15070. PMID:29763518.